My bookmarksSign up free

Commission Implementing Regulation (EU) 2023/1581 of 1 August 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food ‘astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/1581 of 1 August 2023 amending Implementing Regulation (EU) 2017/2470 as regards the conditions of use of the novel food ‘astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ (Text with EEA relevance)

Implementing Regulation (EU) 2023/1581 · Regulation · 4 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.

Article 2

1.   Food supplements containing ≤ 8,0 mg astaxanthin intended for the general population older than 14 years of age, which were lawfully placed on the market before the date of entry into force of this Regulation, may be marketed until their date of minimum durability or use by date. 2.   Food supplements containing ≤ 8,0 mg astaxanthin intended for the general population older than 14 years of age, imported into the Union may be marketed until their date of minimum durability or use by date where the importer of such food can demonstrate that they were dispatched from the third country concerned and were on their way to the Union before the date of entry into force of this Regulation.

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In the Annex to Implementing Regulation (EU) 2017/2470, the entry for ‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae’ in Table 1 (Authorised novel foods) is replaced by the following: Authorised novel food Conditions under which the novel food may be used Additional specific labelling requirements Other requirements ‘Astaxanthin-rich oleoresin from Haematococcus pluvialis algae Specified food category Maximum levels of astaxanthin The designation of the novel food on the labelling of the foodstuffs containing it shall be ‘Astaxanthin rich oleoresin from Haematococcus pluvialis algae’ The labelling of food supplements containing Astaxanthin rich oleoresin from Haematococcus pluvialis algae shall bear a statement that they should not be consumed: (a) if other food supplements containing astaxanthin esters are consumed on the same day (b) by infants and young children under 3 years of age (c) by infants and children under 10 years of age  ( *1 ) (d) by infants, children and adolescents under 14 years of age  ( *1 ) .   Food supplements as defined in Directive 2002/46/EC excluding infants and young children 2,3 mg astaxanthin per day for children 3 to less than 10 years of age 5,7 mg astaxanthin per day for adolescents 10 to less than 14 years of age 8 mg astaxanthin per day for general population older than 14 years of age ( *1 )   Depending on the age group the food supplement is intended for.’

Other acts of the same type
Commission Implementing Regulation (EU) 2025/522 of 13 March 2025 on the registration of the geographical indication Río Negro (PDO) in the Union register of geographical indications pursuant to Regulation (EU) 2024/1143 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/468 of 12 March 2025 opening and providing for the management of Union tariff quotas for certain processed agricultural products originating in the Republic of ChileCouncil Implementing Regulation (EU) 2025/487 of 11 March 2025 implementing Regulation (EU) 2019/1890 concerning restrictive measures in view of Türkiye’s unauthorised drilling activities in the Eastern MediterraneanCommission Implementing Regulation (EU) 2025/498 of 11 March 2025 amending Annex I to Implementing Regulation (EU) 2023/594 laying down special disease control measures for African swine feverCommission Implementing Regulation (EU) 2025/499 of 11 March 2025 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for Canada, the United Kingdom and the United States in the lists of third countries, territories or zones thereof authorised for the entry into the Union of consignments of poultry and germinal products of poultry, and of fresh meat of poultry and game birdsCouncil Regulation (EU) 2025/517 of 11 March 2025 amending Regulation (EU) No 904/2010 as regards the VAT administrative cooperation arrangements needed for the digital ageCouncil Implementing Regulation (EU) 2025/518 of 11 March 2025 amending Implementing Regulation (EU) No 282/2011 as regards information requirements for certain VAT schemesCommission Implementing Regulation (EU) 2025/457 of 10 March 2025 renewing the approval of dinotefuran as an active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/458 of 10 March 2025 correcting certain language versions of Implementing Regulation (EU) 2019/773 on the technical specification for interoperability relating to the operation and traffic management subsystem of the rail system within the European UnionCommission Regulation (EU) 2025/447 of 7 March 2025 amending Regulations (EC) No 2150/2002 and (EC) No 1552/2005 of the European Parliament and of the Council, as well as Commission Regulations (EC) No 1726/1999, (EC) No 1916/2000, (EC) No 198/2006, (EC) No 1062/2008 and (EU) No 349/2011, as regards references to the statistical classification of economic activities NACE Revision 2 established by Regulation (EC) No 1893/2006 of the European Parliament and of the CouncilCommission Implementing Regulation (EU) 2025/454 of 7 March 2025 laying down the rules for the application of Regulation (EU) 2024/1689 of the European Parliament and of the Council as regards the establishment of a scientific panel of independent experts in the field of artificial intelligenceCommission Implementing Regulation (EU) 2025/455 of 7 March 2025 granting a Union authorisation for the single biocidal product SatPax® 70/30 IPA in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next